FDA grapples with gray areas in fast-tracking experimental drugs
Gray areas create agonizing conundrums for agency officials and patient advocates.
Experimental Ebola treatment given to Americans, but when will regulatory pathway extend to sick Africans?
The two Ebola-infected Americans recently evacuated from Liberia were given an experimental drug that probably saved their lives, but Popular Science raises an interesting point – no Africans are likely to get the same treatment. Not anytime soon, that is. Kent Brantly and Nancy Writebol, the two volunteers in an Ebola clinic that contracted the deadly virus, […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.